{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:46:10Z","timestamp":1791665170137,"version":"4.3.4"},"reference-count":18,"publisher":"Scientific Scholar","content-domain":{"domain":["jpalliativecare.com"],"crossmark-restriction":true},"short-container-title":["IJPC"],"abstract":"<jats:sec id=\"st1\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>Anaemia is prevalent in individuals with advanced cancer and may contribute to adversely affecting their quality of life. In palliative care (PC), red blood cell (RBC) transfusions are regularly administered to address bothersome symptoms such as fatigue and dyspnoea. However, they are not without risks and adverse effects in individuals who are often frail at the end of life. Within this context, RBC transfusion benefits and drawbacks have yet to be demonstrated. This study aimed to assess RBCs transfusion-targeted indications, practices and clinical outcomes at the end-of-life in hospitalised patients with advanced malignancy.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st2\">\n<jats:title>Materials and Methods<\/jats:title>\n<jats:p>A retrospective cohort design was used. All adults with a cancer diagnosis admitted to a PC Unit in a tertiary care centre in Saudi Arabia and who received at least one RBC transfusion between 1 January 2020 and 1 January 2024 were included in the study. Data were retrieved from their medical records (demographics, clinical and transfusion episode information) and included the <jats:italic>Charlson Comorbidity Index<\/jats:italic>.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st3\">\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 84 patients were included, comprising a total of 159 episodes of transfusion. Patients had a mean age of 47 years (19.4%). The most frequent location of cancer was the gastrointestinal system (34.6%). For most patients, a low haemoglobin level was the main indication for the transfusion, without precise symptoms being targeted. There was no improvement following several transfusion episodes (82.4%). A moderate negative correlation was observed between age and survival days post-transfusion.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st4\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>There is a need for further studies to better understand the benefits of RBC transfusions at the end of life. In addition, more attention is warranted to establish targeted clinical outcomes pre-transfusion rather than relying on abnormal laboratory values. Validated self-reported tools should be used to ensure the benefits of an intervention that involves such a limited and valuable resource.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/ijpc_356_2024","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T05:27:38Z","timestamp":1745299658000},"page":"186-191","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Blood Transfusions in Patients with Advanced Cancer at the End-of-Life: Are They Really Beneficial?"],"prefix":"10.25259","volume":"31","author":[{"given":"Steven","family":"Callaghan","sequence":"first","affiliation":[{"name":"Oncology Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Sadler","sequence":"additional","affiliation":[{"name":"Oncology Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gassan Adnan","family":"Abudari","sequence":"additional","affiliation":[{"name":"Oncology Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneerah","family":"Almutairi","sequence":"additional","affiliation":[{"name":"Oncology Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma Musaed","family":"Almusaed","sequence":"additional","affiliation":[{"name":"Academic and Training Affairs, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayan","family":"Alqahtany","sequence":"additional","affiliation":[{"name":"Academic and Training Affairs, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nessreen Abu","family":"Alsamh","sequence":"additional","affiliation":[{"name":"Oncology Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Evangelista","sequence":"additional","affiliation":[{"name":"Oncology Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawad","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Oncology Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Yassein","family":"Sroor","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Faculty of Medicine, Cairo University, Cairo, Egypt,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Alkhudairi","sequence":"additional","affiliation":[{"name":"Oncology Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"10.25259\/IJPC_356_2024\/ref-1","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1089\/jpm.2017.0072","article-title":"The Prospective Evaluation of the Net Effect of Red Blood Cell Transfusions in Routine Provision of Palliative Care","volume":"20","author":"To","year":"2017","journal-title":"J Palliat Med"},{"key":"10.25259\/IJPC_356_2024\/ref-2","article-title":"Palliative Care","author":"The World Health Organisation","year":"2020"},{"key":"10.25259\/IJPC_356_2024\/ref-3","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1080\/01635581.2018.1460685","article-title":"Biological and Immunological Aspects of Iron Deficiency Anemia in Cancer Development: A Narrative Review","volume":"70","author":"Zohora","year":"2018","journal-title":"Nutr Cancer"},{"key":"10.25259\/IJPC_356_2024\/ref-4","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/nu13020482","article-title":"Cancer-Related Anemia: An Integrated Multitarget Approach and Lifestyle Interventions","volume":"13","author":"Natalucci","year":"2021","journal-title":"Nutrients"},{"key":"10.25259\/IJPC_356_2024\/ref-5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5603\/PMPI.a2023.0023","article-title":"Blood Transfusions in Palliative Care: A Method to Improve Quality of Life or Double-Edged Sword? A Mini-Review","volume":"17","author":"Bukala","year":"2023","journal-title":"Palliat Med Pract"},{"key":"10.25259\/IJPC_356_2024\/ref-6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11912-019-0832-0","article-title":"Transfusion as a Palliative Strategy","volume":"21","author":"Raval","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"10.25259\/IJPC_356_2024\/ref-7","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1089\/jpm.2016.0073","article-title":"Can We Detect Transfusion Benefits in Palliative Care Patients?","volume":"19","author":"To","year":"2016","journal-title":"J Palliat Med"},{"key":"10.25259\/IJPC_356_2024\/ref-8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/bmjspcare-2018-001494","article-title":"Blood Transfusion Practice in the UK and Ireland: A Survey of Palliative Care Physicians","volume":"9","author":"Neoh","year":"2019","journal-title":"BMJ Support Palliat Care"},{"key":"10.25259\/IJPC_356_2024\/ref-9","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1097\/j.pbj.0000000000000195","article-title":"Transfusion Practices in Patients with Advanced Cancer: A Retrospective Study in a Palliative Care Service","volume":"7","author":"Marote","year":"2022","journal-title":"Porto Biomed J"},{"key":"10.25259\/IJPC_356_2024\/ref-10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/1049909118806456","article-title":"A Retrospective Chart Review of Transfusion Practices in the Palliative Care Unit Setting","volume":"36","author":"Sirianni","year":"2019","journal-title":"Am J Hosp Palliat Med"},{"key":"10.25259\/IJPC_356_2024\/ref-11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1055\/s-0041-1725115","article-title":"Physicians' Opinions on Anticoagulant Therapy in Patients with a Limited Life Expectancy","volume":"47","author":"Huisman","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.25259\/IJPC_356_2024\/ref-12","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1089\/jpm.2024.0108","article-title":"Treatment with Antithrombotics in the Last Year of Life-Incidence of Bleeding and Side Effects After Deprescribing","volume":"27","author":"Frisk","year":"2024","journal-title":"J Palliat Med"},{"key":"10.25259\/IJPC_356_2024\/ref-13","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.7314\/APJCP.2014.15.10.4251","article-title":"Use of blood Transfusion at the End of Life: Does it have any Effects on Survival of Cancer Patients?","volume":"15","author":"Goksu","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.25259\/IJPC_356_2024\/ref-14","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1111\/trf.16560","article-title":"Red Blood Cell Transfusion and Associated Outcomes in Patients Referred for Palliative Care: A Retrospective Cohort Study","volume":"61","author":"Chin-Yee","year":"2021","journal-title":"Transfusion"},{"key":"10.25259\/IJPC_356_2024\/ref-15","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1089\/jpm.2018.0605","article-title":"Red Blood Cell Transfusion in Palliative Care: A Survey of Palliative Care Physicians","volume":"22","author":"Chin-Yee","year":"2019","journal-title":"J Palliat Med"},{"key":"10.25259\/IJPC_356_2024\/ref-16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1089\/jpm.2013.0387","article-title":"Transfusion in Palliative Cancer Patients: A Review of the Literature","volume":"17","author":"Uceda Torres","year":"2014","journal-title":"J Palliat Med"},{"key":"10.25259\/IJPC_356_2024\/ref-17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1182\/blood-2018-03-842575","article-title":"Transfusion Dependence, Use of Hospice Services, and Quality of End-of-life Care in Leukemia","volume":"132","author":"LeBlanc","year":"2018","journal-title":"Blood"},{"key":"10.25259\/IJPC_356_2024\/ref-18","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1200\/JCO.18.02386","article-title":"Palliative and Endof-Life Care for Patients With Hematologic Malignancies","volume":"38","author":"El-Jawahri","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["Indian Journal of Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jpalliativecare.com\/blood-transfusions-in-patients-with-advanced-cancer-at-the-end-of-life-are-they-really-beneficial\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jpalliativecare.com\/blood-transfusions-in-patients-with-advanced-cancer-at-the-end-of-life-are-they-really-beneficial\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T10:32:35Z","timestamp":1748255555000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpalliativecare.com\/blood-transfusions-in-patients-with-advanced-cancer-at-the-end-of-life-are-they-really-beneficial\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":18,"alternative-id":["10.25259\/IJPC_356_2024"],"URL":"https:\/\/doi.org\/10.25259\/ijpc_356_2024","relation":{},"ISSN":["1998-3735","0973-1075"],"issn-type":[{"value":"1998-3735","type":"electronic"},{"value":"0973-1075","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"article-number":"186"}}